January 27, 2023

mRNA treatment market

mRNA treatment market

Market segmentation for mRNA treatment

Market segmentation for mRNA treatment

The size of the global mRNA treatment market is anticipated to grow at a compound annual growth rate (CAGR) of 21.2% from 2022 to 2030 | Reveal InsightAce Analytics

JERSEY, NJ, Jan. 24, 2023 /EINPresswire.com/ — InsightAce Analytic Pvt. ltd announced the release of a market research report titled “Global mRNA Treatment Market – by Product Type (Prophylactic Vaccines, Therapeutic Vaccines, Therapeutic Drugs), Therapeutic Area (Infectious Diseases, Oncological Diseases, Other Diseases), Route of Administration (Intravenous, Intramuscular, Intranasal, Other)) – Market Outlook and Industry Analysis 2030” According to the company’s latest research, the global mRNA treatment market is anticipated to grow rapidly during the forecast period, with a promising CAGR of 21.2% between 2022 and 2030.

The major players covered in this report are:

Prominent market players include CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Stemirna Therapeutics Co., Ltd., Kernal Biologics, Silence Therapeutics, eTheRNA (Etherna ImmunotherapiesIn-Cell-Art, Skyhawk Therapeutics, Inc. , Anima Biotech, H3 Biomedicine Inc., Arcturus Therapeutics, eFFECTOR Therapeutics, Inc., ), Tiba Biotechnology, Ionis Pharmaceuticals, Inc., RNAimmune (Sirnaomics), miRagen Therapeutics, Inc., Ziphius Therapeutics NV, GlaxoSmithKline plc, other prominent players .

Get a free sample copy of the report at https://www.insightaceanalytic.com/request-sample/1110

mRNA, also known as messenger RNA, is a molecule that contains the instructions or recipe that directs cells to produce a protein. mRNA vaccines work by introducing an mRNA fragment that corresponds to a viral protein, typically a short fragment of a protein present on the outer membrane of the virus. The two mRNA treatments, mRNA therapeutics and mRNA vaccines have emerged as promising alternatives to traditional treatments. Several types of mRNA immunotherapies are currently under development. One such strategy is the development of personalized cancer vaccines. It enables scientists to develop mRNA cancer vaccines that stimulate the immune system to attack cancer cells. This involves using genome sequencing to find neoepitope mutations in a patient’s cancer cells.

Conventional vaccines use inactivated microorganisms to stimulate the body’s immune response. mRNA vaccines use genetically modified molecules that instruct your cells to produce a harmless protein fragment of a specific virus. This causes the immune system to produce antibodies tailored to attack and destroy the viral protein. Recent technological advances in stability, translation, and transport have made messenger RNAs a potential therapeutic tool. In fact, mRNA vaccines have opened up new pharmacological areas and have become a leading therapeutic class. These mRNA vaccines are helping to design next-generation vaccines.

The mRNA treatment industry is driven by the increasing incidence of cancer, viral infections and genetic abnormalities. In addition, increasing awareness of vaccination is fueling the global mRNA industry. Additionally, using mRNA to generate viral antigenic proteins inside the cell is one of the most promising treatments for viral diseases. For example, as a result of the COVID-19 outbreak, the number of companies conducting clinical trials for vaccine development is expected to create profitable prospects soon.

Get a custom report at https://www.insightaceanalytic.com/customisation/1110

Increased investments by operational players in the development of innovative and effective drugs and vaccines are expected to spur market growth during the forecast period. For example, in June 2022, Pfizer and Valneva announced the completion of an equity investment for the research and commercialization of prophylactic vaccines against infectious diseases.

The high trial costs, risk of failure, and difficulties associated with mRNA measurement are likely to limit industry expansion. The slow process of FDA approvals and long-term clinical trials are also responsible for market growth limitations.

North America represents the largest share of the global mRNA treatments market, driven in part by growing demand for transformation treatments, increasing funding for infusions, a supportive regulatory environment, and a massively increased focus on establishing precision medicine.

Key Market Developments:

• In September 2022, the Biomedical Advanced Research and Development Authority (BARDA) awarded Arcturus Therapeutics up to $63.2 million to expand its existing influenza vaccine program to develop a pandemic influenza vaccine based on its patented self-amplifying mRNA Technology.

• In June 2022, Pfizer and BioNTech formed a new research, development and marketing collaboration to produce the world’s first mRNA-based vaccine to prevent shingles (herpes zoster virus) (CO). The partnership builds on the success of the companies’ approved mRNA Covid-19 vaccine.

• In April 2022, Arcturus’ self-boosting COVID-19 mRNA vaccine candidate ARCT-154 announced that the Phase 3 study had met the primary efficacy endpoint.

• In September 2021, Sanofi completed its $3.2 billion acquisition of mRNA therapy developer Translate Bio. The mRNA Center of Excellence intends to leverage the potential of next-generation mRNA vaccines and other critical areas including immunology, cancer and rare diseases.

Market segmentation:

Global mRNA Treatment Market, by Product Type, 2022-2030 (Million USD Value)

• Prophylactic vaccines
• Therapeutic vaccines
• Therapeutic drugs

Global mRNA Treatment Market, by Therapeutic Area, 2022-2030 (Million USD Value)

• Infectious diseases
• Oncological diseases
• Other diseases

Global mRNA Treatment Market, by Route of Administration, 2022-2030 (Million USD Value)

• Intravenously
• Intramuscular
• Intranasally
• Other

Global mRNA Treatment Market by Region, 2022-2030 (Million USD Value)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

North America mRNA Treatment Market, by Country, 2022-2030 (Million USD Value)
• US
• Canada
Europe mRNA Treatment Market, by Country, 2022-2030 (Million USD Value)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia-Pacific mRNA Treatment Market, by Country, 2022-2030 (Million USD Value)
• India
• China
• Japan
• South Korea
• Australia and New Zealand

Latin America mRNA Treatment Market, by Country, 2022-2030 (Million USD Value)
• Brazil
• Mexico
• Rest of Latin America

Middle East and Africa mRNA Treatment Market, by Country, 2022-2030 (Million USD Value)
• GCC countries
• South Africa
• Rest of Middle East and Africa

Read the report at https://www.insightaceanalytic.com/report/global-mrna-treatment-market-/1110

Why you should buy this report:
 To acquire a comprehensive analysis of the prospects for the mRNA treatment market.
 To obtain an industry overview and future trends of the mRNA Treatment market.
 Analysis of the drivers and challenges of mRNA treatment market.
 To obtain information about the forecast global mRNA treatment market size by 2030 (value USD million).
 Notable investments, mergers and acquisitions in the Global mRNA Treatment Market industry

Other related reports published by InsightAce Analytics:

Global mRNA Synthesis and Manufacturing Services Market
Global mRNA Synthesis Raw Materials Market
Global mRNA extraction and purification market
Global CDMO Market for Lipid Nanoparticles (LNPs).
Global CDMO Market for Advanced Therapy Medicinal Products

About us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions provide insight into the need for market and competitive intelligence to grow businesses. We help our clients gain a competitive advantage by identifying untapped markets, researching new and competing technologies, segmenting potential markets, and repositioning products. Our expertise lies in delivering syndicated and customized market research reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. GmbH.
Tel: +1 551 226 6109
Email: [email protected]
Visit the website: https://www.insightaceanalytic.com/
Follow us on LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/about/
Subscribe to our business newsletters: https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/

Priyanka Tilekar
Insightace Analytic Pvt. GmbH.
+1 551-226-6109
email us here

Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *